Introduction
Lectins are a group of proteins of non-immune origin, which bind specifically to glycans (Sharon and Goldstein 1998) . They are ubiquitous in the biosphere, having been found in animals, plants, bacteria and viruses. Lectins contain one or more carbohydrate-recognition domain(s) (CRD) defined by the conserved amino acid residues involved in glycan recognition. Based on structural and/or evolutionary sequence similarities, lectins in the biosphere can be classified into >40 families (Tateno 2010) . Jacalin-related lectins (JRLs) are one of the lectin families, which derive from Jacalin isolated from seeds of jack fruit (Artocarpus integrifolia; Sastry et al. 1986) . A number of JRLs have been isolated and characterized from various plant families (Sankaranarayanan et al. 1996; Peumans et al. 1997; Van Damme et al. 1999; Hirano et al. 2000; Nomura et al. 2000; Zhang et al. 2000; Goldstein et al. 2001; Mo et al. 2001; Yagi et al. 2002; Tateno et al. 2003; Nakamura-Tsuruta et al. 2008) . JRLs are subdivided into two subgroups based on their sugar-binding specificities: mannose-(mJRL) and galactose-specific (gJRL) subfamilies (Van Damme et al. 1996) . Most JRLs identified to now belong to mJRL, which consists of the intact subunit of 150 amino acids. The gJRL subfamily is a much smaller subgroup, in which only a few members have been identified, such as Jacalin (Sastry et al. 1986 ), Maclura pomifera lectin (Sankaranarayanan et al. 1996) and MornigaG (Rouge et al. 2003) . Although gJRLs have been extensively used as tools to detect mucin-type O-glycans, an mJRL (BanLec) isolated from the fruit of bananas, Musa acuminata, was recently shown to be a potent inhibitor of HIV-1 infection (Swanson et al. 2010) . BanLec inhibits the entry of the virus into the cell by binding to the high-mannose structures found on the heavily glycosylated envelope protein gp120.
The Jacalin-like domain has also been found in animals. In 1994, a 16 kDa soluble protein termed zymogen granule protein 16 (ZG16p) was identified in zymogen granules of rat pancreas (Cronshagen et al. 1994) . By nucleotide sequencing, rat ZG16p showed amino acid sequence identity to Jacalin of 52% (Cronshagen et al. 1994) . In terms of biological functions, Kleene et al. demonstrated that rat ZG16p is involved in the zymogen granule formation: the condensation of secretary enzymes into dense cores and their binding to the granule membrane. They also proposed that the binding of rat ZG16p to the granule membrane was mediated by the interaction between rat ZG16p and sulfated glycosaminoglycans located at the luminal side of the membrane, since the interaction was inhibited by chondroitinase ABC, which cleaves chondroitin sulfate or dermatan sulfate (Kleene et al. 1999) . On the other hand, the association of rat ZG16p with the granule membrane was only partially inhibited by galactose (Kleene et al. 1999) . Recently, Zhou et al. (2007) demonstrated that ZG16p might mediate the secretion of glycoproteins. More recently, Kanagawa et al. (2011) reported the crystal structures of ZG16p and its paralog ZG16b. ZG16p was proved to have a β-prism fold similar to other plant-derived JRLs (Pratap et al. 2002; Bourne et al. 2004; Meagher et al. 2005) . A positively charged patch was shown to be present on the molecular surface of ZG16p, suggesting that ZG16p might bind to negatively charged, sulfated glycosaminoglycans as proposed previously (Kleene et al. 1999; Kanagawa et al. 2011) . ZG16b also has a β-prism fold, but some amino acid residues of the putative sugar-binding site are different from those of the mannose-type binding site, suggesting altered specificity. From the structural comparison with other JRLs, ZG16p was also implicated to show binding specificity to mannose (Kanagawa et al. 2011) . However, the direct evidence of glycan-binding activity and specificity related to biological functions remained to be clarified.
During the screening of novel endogenous lectins in humans by sensitive glycoconjugate microarray, which was recently developed by our group (Tateno et al. 2008) , we unexpectedly found that ZG16p recognizes polyvalent mannose in a highly selective fashion via the JRL CRD. Further, frontal affinity chromatography (FAC) confirmed that ZG16p binds to both high-density mannose and yeast mannan with high affinity. In agreement with this polyvalent mannose specificity, we demonstrate for the first time that ZG16p binds to pathogenic Candida and Malassezia species heavily coated with mannan. In support of this fungal recognition, ZG16p was detected in mucus-producing cells such as serosanguineous acinar cells of the parotid gland, acinar cells of the pancreas and goblet cells of the intestine, which are involved in self-defense against invading pathogens. Although ZG16p was first demonstrated to recognize sulfated glycosaminoglycans and function as a linker between the submembranous matrix and lipid microdomains, we propose that ZG16p also recognizes pathogenic fungi through unique specificity to polyvalent mannose, which is a key signature of non-self microorganisms in the digestive system.
Results

Subunit structure of recombinant ZG16p
Recombinant ZG16p with (rZG16p-His) or without (rZG16p) a 6 × His tag was expressed in E. coli and purified by affinity chromatography using Ni-NTA agarose and Profinity eXact purification resins, respectively. In SDS-PAGE, rZG16p and rZG16p-His gave virtually single bands at 20 and 16 kDa, respectively, either in the presence or in the absence of 2-mercaptoethanol (2-ME; Supplementary data, Figure S1 ). No significant effect was observed after heat treatment in sample buffer containing SDS and 2-ME, suggesting that the subunit of ZG16p mainly consists of a monomer in agreement with the previous report (Kanagawa et al. 2011) , unlike the JRLs from plants, which form oligomers by non-covalent interactions (Bourne et al. 1999) . Consistently, no hemagglutination activity of rZG16p was observed for rabbit erythrocytes.
Glycoconjugate microarray screening of human ZG16p
The glycan-binding specificity of recombinant ZG16p prepared in both mammalian and E. coli systems was analyzed by a glycoconjugate microarray comprising 98 immobilized compounds (Supplementary data, Figure S2 and Table SI ; Tateno et al. 2008 ). In the mammalian system, ZG16p-p3xFLAG-CMV-14 was transfected into HEK293T cells. The resulting culture supernatant containing secreted recombinant ZG16p was pre-complexed with mouse anti-FLAG mAb and Cy3-labeled donkey anti-mouse IgG (H + L) and directly analyzed by the glycoconjugate microarray as reported previously (Tateno et al. 2008) . The expression of ZG16p in the supernatant was confirmed by western blotting using mouse anti-FLAG mAb ( Figure 1A ). As shown in Figure 1B , ZG16p exhibited highly selective binding to α-and β-mannose-PAA probes. Similar results were also obtained using the purified rZG16p without tags produced by ZG16p-pPAL7 ( Figure 1C ) and rZG16p-His with a C-terminal 6 × His tag produced by ZG16p-pET27b prepared in the bacterial system (Supplementary data, Figure S1 ). No significant binding was observed for glycosaminoglycans immobilized on the array (Supplementary data, Table SI, glycan #86-91) under the experimental conditions used in this experiment.
The conserved amino acid residue Asp151 is probably involved in the formation of hydrogen bonds with O4 and O6 of mannose through its carboxy group in a manner similar to other mJRLs (Bourne et al. 1999 (Bourne et al. , 2004 Pratap et al. 2002; Meagher et al. 2005) . As expected, binding to both α-and β-mannose-PAA probes was abolished by the mutation of Asp151 to either Asn (D151N) or Ala (D151A) ( Figure 1B and C). In competition assays, binding of ZG16p to both α-and β-mannose-PAA probes was inhibited by 50 mM D-mannose, but not by D-galactose, D-glucose and lactose ( Figure 1D ). These results unambiguously indicate that ZG16p specifically recognizes α-and β-mannose-PAA probes via the JRL CRD.
Determination of dissociation constants of ZG16p to mannose and mannan by FAC The binding affinity of ZG16p to mannose was further confirmed by a more quantitative method, in a manner of reverse FAC ( Figure 2A ; . Namely, varying concentrations of rZG16p (0.12-1.92 μM) were successively injected into a mannose-immobilized column and the elution profile was detected by fluorescence based on the tryptophan of the protein (excitation, 285 nm; emission, 350 nm). As shown in Figure 2A , a dissociation constant (K d ) of rZG16p to mannose was calculated to be 1.4 µM, supporting the results obtained by the glycoconjugate microarray (Figure 1) . Interestingly, rZG16p exhibited a similar extent of binding affinity to yeast mannan, with a K d of 1.7 µM ( Figure 2B ). Therefore, these data well support the results obtained by the glycoconjugate microarray (Figure 1 ) and also imply that pathogenic fungi coated with mannan might be target extrinsic ligands for ZG16p.
Tissue expression pattern of ZG16p mRNA Previously, human ZG16p mRNA has been reported to be highly expressed in the liver and moderately in the colon based on northern blotting analysis (Zhou et al. 2007 ). For the same purpose, we performed a quantitative real-time PCR ZG16p recognizes polyvalent mannose using 24 tissues (Figure 3 ). Among them, ZG16p mRNA was strongly detected in the liver, pancreas and small intestine, whereas no detectable level of expression was observed in the bone marrow, spleen and thymus.
Tissue localization of ZG16p
To investigate the tissue localization of ZG16p more in detail, rabbit anti-human ZG16p pAb was raised against rZG16p-His and affinity-purified on a ZG16p-immobilized column. The The ZG16p-p3xFLAG-CMV-14 and ZG16p (D151N)-p3xFLAG-CMV-14 plasmids were transfected into HEK293T cells. After 2 days, the culture supernatants were recovered and blotted with mouse anti-FLAG mAb. (B) The culture supernatants containing WT and D151N were pre-complexed with anti-FLAG mAb (0.5 µg/mL) and Cy3-labeled donkey anti-mouse IgG (H + L) (0.75 µg/mL) at room temperature for 15 min, and then applied onto a glycoconjugate microarray (ver. 4.2). (C) WT and mutant forms (D151N and D151A) of rZG16p were pre-complexed with anti-ZG16p pAb (2 µg/mL) and Cy3-labeled donkey anti-rabbit IgG (H + L) (1 µg/mL). (D) Inhibition assay. rZG16p-His was incubated with the glycoconjugate microarray either in the presence or in the absence (control) of 50 mM of mannose (Man), galactose (Gal), glucose (Glc) and lactose (Lac). Glycans used for the glycoconjugate microarray are shown in Supplementary data, Figure S2 and Table SI. purified pAb specifically stained Chinese hamster ovary cells transfected with ZG16p-p3xFLAG-CMV-14, but not untransfected cells in both immune staining and western blotting experiments (Supplementary data, Figure S3 ). Using the generated anti-ZG16p pAb, the immunohistochemical localization of human ZG16p was examined (Figures 4 and 5) . Tissue localization of rat ZG16p has been reported previously (Cronshagen et al. 1994) . Rat ZG16p was detected in acinar cells of the pancreas and goblet cells of the duodenum and colon. In agreement with the results obtained for the rat homolog, acinar cells of the pancreas and goblet cells of the small bowel, colon, appendix and rectum in the lower digestive system were specifically stained with anti-ZG16p pAb ( Figure 4 ). We then analyzed whether ZG16p is expressed in the upper digestive system and found that serosanguineous acinar cells of the parotid gland were significantly stained with anti-ZG16p pAb ( Figure 5 ). Much The immunoreactions were visualized with DAB (brown) and counterstained with hematoxylin (blue). Scale bar, 100 μm.
ZG16p recognizes polyvalent mannose weaker staining was observed using rabbit pre-immune IgG, indicating that the staining is due to anti-ZG16p pAb. The results could be supported using anti-ZG16 mAb (clone #88-7; data not shown). It should be noted that a recombinant ZG16b, a paralog of ZG16p, cross-reacted with neither anti-ZG16p pAb nor mAb (clone #88-7) when analyzed by western blotting. This indicates that the staining is due to the presence of ZG16p. No significant staining was observed in other tissue arrays (Supplementary data, Table SII), including the lymph node, spleen and thymus, in agreement with the results obtained by real-time PCR. Endothelial cells were not significantly stained with the anti-ZG16p pAb at least in this experiment, demonstrating that ZG16p is not expressed in immune cells such as myeloid cells and endothelial cells. Interestingly, ZG16p was detected in human serum analyzed by immunoprecipitation and western blotting using the anti-ZG16p pAb ( Figure 6 ).
ZG16p recognizes live pathogenic fungi
Considering the fact that ZG16p exhibited binding affinity to mannan (Figure 2 ), we postulated that pathogenic fungi might be extrinsic ligands for ZG16p. To test this hypothesis, rZG16p (10 μg/mL) was pre-complexed with anti-ZG16p mAb clone #88-7 (40 μg/mL) and PE-labeled goat anti-mouse IgG (Fc) (40 μg/mL) and incubated with 1 × 10 6 fungi on ice for 1 h. Binding was then analyzed by flow cytometry. As shown in Figure 7A , rZG16p bound to both pathogenic (Candida and Malassezia species) and non-pathogenic (S. cerevisiae) fungi, both of which are heavily coated with mannan, whereas no binding was observed for C. neoformans and S. pombe, which express glucuronoxylomannan and galactomannan as major components, respectively (Chiba and Jigami 2007) .
The binding of rZG16p to C. albicans was inhibited by α-and β-mannose-PAA probes in a concentration-dependent manner ( Figure 7B ). Mutation of Asp151 to either Asn (D151N) or Ala (D151A) in the ligand-binding site reduced binding activity to C. albicans to 35 or 5%, respectively ( Figure 7C ). These results indicate that ZG16p binds to fungi via the JRL CRD.
Capturing pathogenic fungi by ZG16p
Candida species are the most frequent cause of lifethreatening invasive fungal infections in the immunocompromised host. Candida albicans resides as commensals of mucosae and the intestinal tract. Upon invasion, C. albicans passes across the bowel wall into the bloodstream (Cole et al. 1989 (Cole et al. , 1996 de Repentigny et al. 1992) . Given ZG16p's binding activity to Candida species, it is possible to postulate that ZG16p acts as a resistance barrier for fungal infection. In order to test this possibility, i.e. ZG16p's capturing capability for pathogenic fungi, fluorescently labeled live C. albicans was incubated with glass slides immobilized with either WT or a mutant form (D151N) of ZG16p at varying concentrations from 2 to 500 µg/mL in triplicates ( Figure 8A ). Bound fungi were detected with the evanescent-field fluorescence-assisted scanner. As shown in Figure 8B , C. albicans bound to ZG16p-immobilized glass slides. Moreover, ZG16p showed capturing activity to a series of other fungi such as C. glabrata, C. kefyr, C. krusei and S. cerevisiae expressing mannan, but not S. pombe, in agreement with the results obtained by flow cytometry (Figure 7 and Supplementary data, Figure S4 ; Chiba and Jigami 2007) . Mutation of Asp151, the conserved amino acid residue . ZG16p is localized in human serum. Human serum was immunoprecipitated with rabbit anti-ZG16p pAb and pre-immune rabbit IgG control (10 μg/mL) and blotted with anti-ZG16p pAb (1 μg/mL). rZG16p (5 ng) was also run as a positive control.
H Tateno et al. Fig. 7 . Binding of ZG16p to live pathogenic fungi. (A) rZG16p (10 μg/mL) was pre-complexed with anti-ZG16p mAb clone #88-7 (40 μg/mL) and PE-labeled goat anti-mouse IgG (Fc) (40 μg/mL) and then incubated with 1 × 10 6 live fungi on ice for 1 h (black line). Binding was analyzed by flow cytometry. Control represents staining without ZG16p (gray). (B) Inhibition assay. ZG16p was pre-incubated with α-and β-Man-PAA probes at varying concentrations from 10 to 100 μg/mL and then incubated with C. albicans. Data are shown relative to ZG16p binding without inhibitors. (C) WT and mutant forms (D151N and D151A) of rZG16p (10 μg/mL) were pre-complexed with anti-ZG16p pAb (20 μg/mL) and Cy3-labeled donkey anti-rabbit IgG (H + L) (10 μg/mL) and then incubated with 1 × 10 6 C. albicans. Data are shown relative to binding of WT ZG16p. Fig. 8 . Capturing live pathogenic fungi by ZG16p. (A) rZG16p-His and its mutant D151N were spotted onto glass slides at varying concentrations ranging from 2 to 500 μg/mL. (B) Candida albicans (1 × 10 6 ) was fluorescently labeled with 20 μM Cell-Tracker CMRA and then applied onto the ZG16p-immobilized glass slides either in the presence or in the absence of 100 μg/mL inhibitors. Bound fluorescence was detected by the evanescent-field fluorescence-assisted scanner. (C) Mannan (1 μg/mL) from C. albicans was labeled with Cy3 and applied onto the ZG16p-immobilized glass slides.
ZG16p recognizes polyvalent mannose required for mannose-binding, abolished binding activity to C. albicans ( Figure 8B) . Binding of C. albicans to the immobilized ZG16p was inhibited in the presence of 100 µg/ mL C. albicans mannan. Furthermore, direct binding of ZG16p to C. albicans mannan was also observed ( Figure 8C ). These results demonstrate that ZG16p is capable of capturing C. albicans through specific binding to the cell wall mannan. Notably, no inhibitory effect was observed for bovine thyroglobulin containing high-mannose-type N-glycans, indicating that endogenous glycoproteins expressing high-mannose-type N-glycans might not function as ligands for ZG16p. However, no inhibitory activities of fungal cell growth and adhesion to the human epithelial colorectal adenocarcinoma Caco2 cell line were observed under the experimental conditions used in this study.
Discussion
Although lectins are simply defined as glycan-binding proteins, a protein cannot be easily assigned as the one by the presence of evolutionarily related CRDs. The protein must be proved to have glycan-binding activity through its CRD. At least 13 lectin families have been investigated in humans: they include Calnexin, M-type, L-type, P-type, R-type, Galectins, I-type, C-type, F-box proteins and Ficolins (http:// www.imperial.ac.uk/research/animallectins/default.html), which participate in diverse biological processes, such as sorting and quality control of glycoproteins, regulation of cellular communication and responses and foreign microbial recognition. However, the full repertoire of endogenous lectins in humans remains unidentified, while almost all of the human glycosyltransferases have been evaluated for their donor/acceptor specificities. To identify novel endogenous lectins in humans, we previously developed a glycoconjugate microarray based on the evanescent-field fluorescence-assisted detection system (Tateno et al. 2008) . The advantage of this system includes the wash-free equilibrium detection of relatively weak sugarprotein interactions by immobilization of high-affinity multivalent glycopolymers on the array, which contributes to substantial increase in sensitivity. Using this system, we have already succeeded in finding novel glycan-binding properties of some endogenous lectins, such as Mincle (Yamasaki et al. 2009 ) and Langerin , both of which are members of the C-type lectin family, one of the largest families in humans.
To extend the scope of this project, we searched the human genome using a bioinformatics approach. The selected lectin candidates were expressed as recombinant proteins in HEK293T cells, and their glycan-binding capabilities were investigated by the glycoconjugate microarray. One of the candidates was ZG16p, which has the Jacalin-like domain, but its glycan-binding properties have not been fully elucidated. As shown in Figure 1 , ZG16p exhibited significant binding to mannose-conjugated PAA probes, behavior similar to that of other mJRLs isolated from plants, although its affinity to mannose monosaccharide seemed to be much lower. To determine binding affinity to mannose, we attempted FAC by following the conventional analytical procedure (Tateno, Nakamura-Tsuruta, et al. 2007 ). However, ZG16p immobilized on agarose at concentrations up to 4.8 mg/mL showed no substantial binding to a panel of pyridylaminated glycans including high-mannose-type N-glycans. We therefore applied a reverse-FAC assay, where varying concentrations of ZG16p were passed through mannose-immobilized columns. Binding affinity to the mannose-immobilized agarose was determined to be 1.3 µM in terms of K d . It should be noted, however, that the obtained K d value is not simply assigned for mannose monosaccharide, because high-density mannose residues have been immobilized on agarose. In other words, K d values should vary depending on the mannose density. Together with the result obtained by the glycoconjugate microarray showing no binding to glycoproteins containing high-mannose-type N-glycans such as thyroglobulin and invertase, ZG16p is considered to require a polyvalent feature of high-mannose density for substantial binding. The low affinity to mannose monosaccharide might also be attributed to the monomeric structure of ZG16p, unlike other members of the JRL family, which form multimers.
Historically, most lectins have been identified through agglutination and binding assays using model cells and glycoproteins. Therefore, the low affinity to monosaccharide and no hemagglutination activity explain why the mannose specificity of ZG16p has not been easily unveiled. In this sense, the present screening system utilizing an evanescent-field fluorescence-assisted detection principle proved to work in a manner highly suited to the discovery of such "atypical" lectins, i.e. those with low affinity and no apparent cell agglutination activity. However, in order to cover the full lectin repertoire, there are still limitations in the current screening system: first, a glycan library immobilized on the current glycoconjugate microarray is not large enough to cover a wide range of lectin specificities. Second, the current glycoconjugate microarray approach would not identify lectins such as CLEC2 that recognize both glycan and protein structures (Kato et al. 2008) . Third, in case no information is available about the sugar-binding activity of a certain protein fold (family), no proteins belonging to this family would be nominated as "candidates". Development of a more comprehensive lectinomics approach is necessary.
Previously, ZG16p was reported to bind to sulfated glycosaminoglycans (Cronshagen et al. 1994) . ZG16p is a basic protein ( pI 9.4) containing 13% basic amino acids. Recent X-ray crystallography analysis of ZG16p revealed that there is a positively charged patch on the molecular surface, which could interact with negatively charged molecules, such as sulfated glycosaminoglycans (Kanagawa et al. 2011) . In this sense, ZG16p is likely to be a unique lectin with dual specificity to sulfated glycosaminoglycans and polyvalent mannose. If this is the case, ZG16p should have various physiological functions in human.
Polyvalent mannose is a key signature of non-self (exogenous) microorganisms, which are often infectious toward animals. Our preliminary lectin microarray analysis of the cell surface glycomes of fungi, including Candida and Malassezia species, revealed that they are generally recognized by mannose-binding plant lectins, but not by other lectins with distinct specificities (Shibazaki et al. in press) . Furthermore, ZG16p was specifically detected in mucus-producing cells such as serosanguineous acinar cells of the parotid gland, acinar cells of the pancreas and goblet cells of the intestine, which are involved in self-defense against infectious agents including fungi, bacteria and viruses. We therefore hypothesized that pathogenic fungi heavily coated with polyvalent mannose could be physiological targets for ZG16p. Here, we showed a strong and a series of biochemical evidence that ZG16p is a novel lectin, recognizing various pathogenic fungi including Candida and Malassezia species through specific binding to polyvalent mannose in the intestinal tract, while discrimination between self and non-self is an important issue in immunology. Candida species are the most frequent cause of life-threatening invasive fungal infections in the immunocompromised host (Beck-Sague and Jarvis 1993). The leading cause of candidiasis, C. albicans, resides as a commensal of the mucosa and intestinal tract (Arendorf and Walker 1980) . Upon infection, C. albicans invades the blood stream through the bowel wall. In this context, ZG16p was detected in goblet cells, which secrete a large quantity of mucin forming a protective layer of gel-like mucus over the surface epithelium (Duerkop et al. 2009 ). The mucus layer at the intestinal mucosal surface acts as a resistance barrier to fungal infection (de Repentigny et al. 2000) . Therefore, ZG16p secreted in the mucus layer might help to monitor and regulate the pathogenic fungi, which penetrate into deeper host tissues in a cooperative manner with epithelial anti-microbial proteins, such as defensins (Salzman et al. 2007) .
Although neither inhibitory activity of fungal cell growth or adhesion to epithelial cells have been observed, we have shown the accumulated data regarding localization and sugarbinding function of ZG16p toward fungi. Hence, ZG16p is considered to contribute to the immune system by physically capturing and/or sensing pathogenic fungi. Considering the fact that ZG16p is an evolutionarily highly conserved gene distributed from fishes to human (Zhou et al. 2007 ), the protein might be a novel evolutionarily ancient molecule required for immune system in the digestive system. Since BanLec from the fruit of bananas, M. acuminata, belonging to the same subfamily (mJRL) as ZG16p, was recently shown to be a potent inhibitor of HIV-1 infection (Swanson et al. 2010) , it is reasonable to speculate that lectins of this subfamily might have a role to protect against invading pathogens, which are often coated with polyvalent mannose.
Materials and Methods
Materials
Cy3-labeled donkey anti-mouse immunoglobulin G (IgG) (H + L), Cy3-labeled donkey anti-rabbit IgG (H + L) and phycoerythrin (PE)-labeled goat anti-mouse IgG (Fc) were purchased from Jackson ImmunoResearch (West Grove, PA). Anti-FLAG monoclonal antibody (mAb), clone M2, Saccharomyces cerevisiae mannan-agarose, mannose-agarose, S. cerevisiae mannan and porcine thyroglobulin were purchased from Sigma-Aldrich (Tokyo, Japan). Alkaline phosphatase-conjugated goat anti-rabbit IgG was purchased from Promega (Madison, WI). α-and β-mannosepolyacrylamide (PAA)-biotin probes were purchased from Glycotech (Gaithersburg, MD). Formalin-fixed, paraffinembedded tissue array slides of human normal organs were purchased from SuperBioChips (Seoul, Korea). The human ZG16 cDNA was purchased from Funakoshi Co. (Tokyo, Japan). Protein A-Sepharose 4 Fast Flow was purchased from GE Healthcare UK Ltd (Little Chalfont, England). p3xFLAG-CMV-14 was purchased from Sigma-Aldrich. pET-27b was purchased from Merck Japan (Tokyo, Japan). pPAL7 was purchased from Bio-Rad Laboratories, Inc. (Richmond, CA). Human serum was purchased from Kohjin Bio Co. Ltd (Saitama, Japan).
Preparation of recombinant ZG16p expression constructs
For ZG16p-p3xFLAG-CMV-14, the full-length human ZG16p gene (1-167 amino acids) was amplified with polymerase chain reaction (PCR) using the primer sets (forward: 5′-AAGCTTCCCAGAATGTTGACAGTCGCT-3′ and reverse: 5′-TCTAGAGCATCTGCTGCAGCTAGTGGGGT-3′) and ligated into a p3xFLAG-CMV-14 vector via NdeI and XbaI sites. For ZG16p-pET27b, the human ZG16p gene (17-167 amino acids) was amplified with PCR using the primer sets (forward: 5′-CATATGAATGCCATTCAGGCCAGGTCTTCCT CCTAT-3′ and reverse: 5′-CTCGAGGCATCTGCTGCAGCT AGTGGGGTAAACATC-3′) and ligated into a pET27b vector via NdeI and XhoI sites. For ZG16p-pPAL7, the human ZG16p gene (17-167 amino acids) was amplified by PCR using the primer sets (forward: 5′-AAGCTTTGAATGCCAT TCAGGCCAGGTCTTCCTCCTAT-3′ and reverse: 5′-GAA TTCTCAGCATCTGCTGCAGCTAGTGGGGTAAACATC-3′) and ligated into a pPAL7 vector via HindIII and EcoRI sites. In order to prepare human ZG16p mutants, site-directed mutagenesis of human ZG16p was performed using the Genetailor site-directed mutagenesis system (Invitrogen, Tokyo, Japan). The primers used for the construction of ZG16p mutants were as follows: for D151N, 5′-GCCGGTCTGGTTCTCTCATCA ATGCCATTGGCC-3′ (sense) and 5′-GATGAGAGAACCAG ACCGGCCACTGATGAA-3′ (antisense); for D151A, 5′-GC CGGTCTGGTTCTCTCATCGCTGCCATTGGCC-3′ (sense) and 5′-GATGAGAGAACCAGACCGGCCACTGATGAA-3′ (antisense).
Expression and purification
Expression vectors, ZG16p-pET27b and ZG16p-pPAL7, were used for transformation of Escherichia coli BL21-CodonPlus (DE3)-RIL strain (Agilent Technologies, Santa Clara, CA). Recombinant proteins were expressed in E. coli under the control of IPTG at 20°C overnight and purified with Ni-NTA agarose (Qiagen, GmbH, Germany) or Profinity eXact purification resins in accordance with the manufacturer's procedure (Bio-Rad Laboratories, Inc.). The purified proteins were desalted and concentrated with Amicon Ultra-15 (Millipore, Billerica, MA). rZG16p-His represents recombinant ZG16p with a C-terminal 6 × His tag produced by ZG16p-pET27b, whereas rZG16p denotes recombinant ZG16p without tags produced by ZG16p-pPAL7.
Production of Abs
Rabbit anti-human ZG16p polyclonal antibody ( pAb) was raised against rZG16p-His by a local contractor (Operon ZG16p recognizes polyvalent mannose Biotechnology, Tokyo, Japan). The Ab fraction recognizing ZG16p was purified by affinity chromatography on an rZG16p-His-conjugated agarose. Mouse anti-human ZG16p mAbs were produced by fusing myeloma cells with splenocytes from a mouse, which had been immunized with rZG16p-His by a local contractor (MBL, Nagoya, Japan). The mAbs were then assayed for their ability to bind to ZG16p by ELISA, western blotting, glycoconjugate microarray and immune fluorescence staining (data not shown). Clones #88-2 and 88-7, which can be used in all of the above assays, were purified by affinity chromatography on Protein A-Sepharose and used in this study.
Glycoconjugate microarray
Glycoconjugate microarray was performed as described previously (Tateno et al. 2008) . The ZG16p-p3xFLAG-CMV-14 and ZG16p (D151N)-p3xFLAG-CMV-14 plasmids were transfected into HEK293T cells using Lipofectamine LTX (Invitrogen). After 2 days, the culture supernatants were recovered, pre-complexed with 0.5 µg/mL anti-FLAG mAb and 0.75 µg/mL Cy3-labeled donkey anti-mouse IgG (H + L) at room temperature for 15 min and then applied onto a glycoconjugate microarray (ver. 4.2). Wild-type (WT) and mutant forms (D151N and D151A) of rZG16p were pre-complexed with 2 µg/mL anti-ZG16p pAb and 1 µg/mL Cy3-labeled donkey anti-rabbit IgG (H + L) and then applied onto the glycoconjugate microarray. After incubation at 20°C, binding was detected by the evanescent-field fluorescence-assisted scanner, SC-profiler (GP Biosciences Ltd, Yokohama, Japan). Glycans used for the glycoconjugate microarray are shown in Supplementary data, Figure S1 and Table SI .
Frontal affinity chromatography
The principle and the protocol of FAC have been described previously (Nakamura-Tsuruta et al. 2006; Tateno, Nakamura-Tsuruta, et al. 2007 ). Briefly, mannan-and mannose-agarose gels were packed into miniature columns (inner diameter, 2 mm; length, 10 mm; bed volume, 31.4 µL; Shimadzu, Kyoto, Japan) and connected to a highperformance liquid chromatograph (Shimadzu). Varying concentrations of rZG16p (0.12-1.92 μM) were successively injected into the columns. The elution profile was detected by fluorescence (excitation, 285 nm; emission, 350 nm). The elution front of rZG16p relative to that of BSA (negative control), referred to V − V 0 , was then determined. The WoolfHofstee plots were made using the V − V 0 values. The intercept and the slope of the fitted line represent B t (nmol) and −K d (μM), respectively.
Real-time PCR
Marathon ReadyTM cDNAs derived from various human tissues were purchased from Clontech Laboratories, Inc. (Mountain View, CA). Real-time PCR was performed using an ABI PRISM 7700 Sequence Detection System (Life Technologies Japan Ltd, Tokyo, Japan) as described previously (Iwai et al. 2002; Sato et al. 2006) . Standard curves for the human ZG16p gene and the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene, as an endogenous control, were generated by serial dilution of each plasmid DNA. Data are shown as the relative amount of human ZG16p transcript normalized by the amount of GAPDH transcript in the same cDNA.
Tissue staining
Tissue staining was performed using a Histofine SAB-PO(R) kit (Nichirei Biosciences, Inc., Tokyo, Japan) in accordance with the manufacturer's procedure. After drying at 60°C for 1 h, the tissue arrays were deparaffinized with xylene and rehydrated with ethanol. After autoclaving at 121°C for 20 min to unmask antigen, they were immersed in 0.3% hydrogen peroxide for 15 min to inhibit endogenous peroxidase activity. After blocking with 10% goat normal serum, the tissue arrays were incubated with 10 µg/mL rabbit anti-ZG16p pAb and pre-immune rabbit IgG for 1 h at room temperature. After washing with PBS (10 mM phosphate buffer, pH 7.2, containing 0.15 M NaCl), the arrays were incubated with biotinconjugated anti-rabbit IgG for 15 min at room temperature. After washing with PBS, they were incubated with peroxidase-conjugated streptavidin for 10 min at room temperature. The immunoreactions were visualized using a Histofine DAB substrate kit (brown; Nichirei Biosciences, Inc.) and counterstained with hematoxylin (blue; Vector Laboratories, Inc., CA). Finally, the tissue arrays were dehydrated and mounted with VectaMount Permanent Mounting Medium (Vector Laboratories). Images were acquired using a BZ-9000 fluorescence microscope (Keyence, Osaka, Japan).
Immunoprecipitation and western blotting
After pre-clearing, human serum (200 μL) was incubated with Protein A-Sepharose immobilized with either rabbit anti-ZG16p pAb (10 μg/mL, 10 μL) or pre-immune rabbit control IgG at 4°C overnight. After washing with PBS-T (PBS containing 1% Triton X-100), bound fractions were eluted with SDS sample buffer at 95°C for 5 min, run on SDS-PAGE, and electroblotted onto a PVDF membrane. After blocking with 3% BlockAce (DS Pharma Biomedical Co., Osaka, Japan), the membrane was incubated with 1 μg/ mL anti-ZG16p pAb at room temperature for 1 h. After washing with TBS-T (Tris-buffered saline containing 0.1% tween-20), the membrane was incubated with alkaline phosphatase-conjugated goat anti-rabbit IgG (Promega, Tokyo, Japan) at room temperature for 30 min. After washing with TBS-T, the membrane was visualized with Western blue stabilized substrate for alkaline phosphatase (Promega). 
, Schizosaccharomyces pombe (40138) and Cryptococcus neoformans (B4500) were obtained from the National BioResource Project (http://www.nbrp.jp/). Saccharomyces cerevisiae, C. neoformans and Candida species were cultured H Tateno et al. in YPD medium (2% peptone, 1% dried yeast extract, 2% glucose, pH 5.8). Malassezia species were cultured in YPD medium containing olive oil.
Flow cytometry
A sample of rZG16p (10 µg/mL) was pre-complexed with anti-human ZG16p mAb clone #88-7 (40 µg/mL) and PE-labeled goat anti-mouse IgG (Fc; 40 µg/mL) in PBS containing 1% BSA (PBS/BSA) at room temperature for 30 min and then incubated with live fungi (1 × 10 6 ) on ice for 1 h. WT and mutant forms of rZG16p (10 µg/mL) were precomplexed with anti-ZG16p pAb (20 µg/mL) and Cy3-labeled donkey anti-rabbit IgG (H + L) (10 µg/mL). After washing with PBS/BSA, flow cytometry data were acquired on a FACSCanto-II cytometer (BD Biosciences, San Jose, CA) and analyzed using the FlowJo software (TreeStar, Ashland, OR). For the inhibition assay, rZG16p was preincubated with α-or β-mannose-PAA probes at concentrations ranging from 10 to 100 μg/mL.
Capturing assay
A capturing assay was performed as described previously ). Briefly, rZG16p-His and its mutant D151N were spotted on an epoxy-coated glass slide (Schott, Mainz, Germany) using a non-contact microarray printing robot, Microsys 4000 SYSTEM (Genomic solutions Inc., MI) at varying concentrations ranging from 2 to 500 μg/mL. Candida albicans was fluorescently labeled with 20 μM Cell-Tracker CMRA (Invitrogen) and applied onto the ZG16p-immobilized glass slides either in the presence or in the absence of 100 μg/mL inhibitors. Bound fluorescence was detected by the evanescent-field fluorescence-assisted scanner.
Inhibition assay of fungal cell growth About 1 × 10 6 of C. albicans and C. glabrata were incubated with 10-100 μg/mL of ZG16p in PBS at 37°C for 2 h. After serial dilution with PBS, 5 μL was spotted onto YPD plates and further cultured at 30°C overnight. Fungal cell growth was then visually observed.
Inhibition assay of fungal cell adhesion to epithelial cells The human epithelial colorectal adenocarcinoma cell lines, Caco2 cells (1 × 10 5 /well), were cultured in a 24-well plate for 2 days. Three hundreds of C. albicans incubated with either in the presence or in the absence of ZG16p (0.3 mg/ mL) for 1 h at room temperature in PBS were then applied onto Caco2 cells and further incubated with 0, 120 and 240 min. After incubation, the culture supernatant (non-adherent fungi) and cells (adherent fungi) were recovered and applied onto YPD plates. After culturing at 30°C overnight, the cell numbers of non-adhesive and adhesive C. albicans to Caco2 cells were counted.
Supplementary data
Supplementary data for this article is available online at http:// glycob.oxfordjournals.org/.
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